Illumina Inc (ILMN)
Health Care ยท Laboratory Analytical Instruments
Illumina Inc (ILMN) is listed on Nasdaq, where its shares have traded since July 28, 2000. SentiSense covers Illumina Inc in the Health Care sector, and its Standard Industrial Classification is Laboratory Analytical Instruments. Jacob Thaysen is its chief executive officer. The company reports 8,650 employees, and its corporate website is www.illumina.com.
About Illumina Inc
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 923 institutions reported holding ILMN, with 155.7 million shares worth $27.4 billion in aggregate. The largest reported holders were BlackRock, Capital Group and Vanguard. Of the 5 largest reported holders, 3 added shares and 2 reduced their positions during the quarter.
More on ILMN
- ILMN sentiment: whether news and social coverage of Illumina Inc leans bullish or bearish, and the stories driving it.
- ILMN ownership: all 923 reporting institutions, plus insider and congressional trades.
- ILMN financials: revenue, net income, operating margin and free cash flow by quarter and year.
SentiSense also tracks daily options readings for Illumina Inc: IV rank, put/call percentile, 25-delta skew and open-interest walls.
Frequently asked questions
What does Illumina Inc do?
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications.
What sector is ILMN in?
SentiSense classifies Illumina Inc in the Health Care sector, and its Standard Industrial Classification is Laboratory Analytical Instruments.
Where does ILMN stock trade?
Illumina Inc (ILMN) is listed on Nasdaq, where its shares have traded since July 28, 2000.
Who is the CEO of Illumina Inc?
Jacob Thaysen is the chief executive officer of Illumina Inc.